Hb [12–15.5 g/dL] |
8.8 |
8.9 |
9.1 |
9.3 |
10.4 |
10.8 |
10.6 |
10.8 |
10.7 |
TLC [4000– 11000 cell per mm3] |
3,400 |
3,700 |
3,840 |
4,500 |
5,400 |
9,800 |
14,000 |
13,420 |
14,700 |
DLC [60–75% polymorphs, 20–40% lymphocytes, 2–6% monocytes, Eosinophils: 1–4%] |
88/10/1/1 |
77/20/2/1 |
79/20/1 |
82/17/1 |
88/10/1/1 |
87/12/1 |
88/11/1 |
90/8/1/1 |
91/7/1/1 |
Hematocrit [For men; 38.3 to 48.6%] |
35.9 |
36.2 |
35.7 |
34.7 |
35.2 |
35.6 |
|
|
|
Reticulocyte count [0.5 to 2.5%.] |
0.50 |
0.7 |
1.1 |
|
1.2 |
|
|
|
|
Platelets 1.5 to 4.0 × 109 cells per mm3] |
20,000 |
22,000 |
66,000 |
1,25,000 |
1,55,000 |
2,50,000 |
2,65,000 |
2,34,000 |
2,13,000 |
Bilirubin– T/D (1.3 mg/dL)/ 0.3 mg/dL] |
0.89 |
0.48 |
1.6/1.1 |
1.2/0.7 |
1.1/0.9 |
0.7/0.2 |
0.6/0.2 |
0.9/0.2 |
0.8/0.1 |
AST [15–45 U/L] |
4,688 |
9,060 |
11,062 |
8,500 |
5,680 |
1,244 |
960 |
546 |
225 |
ALT [5–50 U/L] |
6,680 |
9,156 |
12,100 |
9,100 |
6,210 |
2,380 |
1,320 |
939 |
726 |
ALP [38–125 U/L] |
188 |
234 |
218 |
255 |
229 |
178 |
210 |
188 |
33 |
Blood Urea/ Serum creatinine [(19–43 mg/dL)/(0.66–1.26 mg/dL)] |
30/0.5 |
32/0.6 |
38/0.9 |
33/0.8 |
29/0.7 |
33/0.8 |
76/1.8 |
98/2.8 |
|
Sodium/Potassium [(137–145 mmol/L) /(3.5–5.1 mmol/L)] |
137/4.1 |
133/4.6 |
140/4.5 |
137/4.1 |
141/4.4 |
143/4.4 |
138/4.1 |
142/4.4 |
143/4.7 |
Total protein/ Serum albumin [(6.3–8.2 g/dL) / (3.5–5.0 g/dL)] |
5.0/2.6 |
4.8/2.6 |
4.9/2.7 |
5.1/2.8 |
5.0/2.8 |
5.2/2.9 |
5.3/2.9 |
|
|
Uric acid [3.4–7.0 mg/dL (male)] |
1.9 |
|
|
|
|
|
|
|
|
CPK–T/MB [10–120 IU/ L / 5 – 25 IU/L ] |
|
113/56 |
145/43 |
125/34 |
|
|
114/36 |
90/33 |
113/39 |
Blood Culture |
|
Sterile |
Sterile |
Sterile |
Sterile |
|
Sterile |
Candida auris sensitive to caspofungin resistant to fluconazole |
Candida auris sensitive to caspofungin, resistant to fluconazole |
Urine culture |
|
E. coli sensitive to nitrofurantoin, colistin, rest all resistant |
Sterile |
Sterile |
Sterile |
|
Sterile |
Sterile |
Sterile |
Urine routine microscopy |
No active sediments, no sugar/protein. |
No active sediments, no sugar/protein. |
No active sediments, no sugar/protein. |
No active sediments, no sugar/protein. |
No active sediments, no sugar/protein. |
|
No active sediments, no sugar/protein. |
No active sediments, no sugar/protein. |
No active sediments, no sugar/protein. |
Peripheral blood Smear |
Pancytopenia with normocytic normochromic blood picture, occasional tear drop cells and elliptocytes seen along with reduced WBCs and platelets. |
Bicytopenia with mild anisocytosis, occasional elliptocytes, tear drop cells and few target cells seen. No atypical cells or schistocytes seen. |
Bicytopenia with reduced platelet counts, shift to the left in WBCs, toxic granules in neutrophils seen. No atypical, haemoparasites or schistocytes seen. |
Thrombocytopenia with large sized platelets seen. |
|
|
|
|
|
Serum Inflammatory Markers
|
LDH [120–146 U/L] |
8,918 |
9,340 |
14,000 |
12,000 |
9,800 |
8,700 |
11,300 |
13,400 |
13,788 |
D–dimer [ <500 ng/mL] |
>5,000 |
>5,000 |
>5,000 |
4,700 |
3,600 |
3,320 |
>5,000 |
>5,000 |
>5,000 |
INR [0.9 to 1.1] |
1.3 |
1.6 |
1.4 |
1.2 |
1 |
1 |
1.1 |
1.1 |
1 |
Hs–CRP [0.0–5.0 mg/L] |
13.11 |
7.38 |
45 |
66 |
52 |
44 |
76 |
112 |
156 |
IL−6 [<7 pg/mL] |
2.8 |
5.6 |
19.8 |
24 |
20 |
21 |
76 |
123 |
233 |
NT–PRO BNP [< 125 pg/mL for age 0–74 years] |
67 |
72 |
109 |
78 |
67 |
60 |
187 |
118 |
104 |
Serum Ferritin [Male = 30–400 ng/mL] |
>2,000 |
3,900 |
4,360 |
1,580 |
1,270 |
1,200 |
>2,000 |
>2,000 |
>2,000 |
Serum Procalcitonin [Low risk: <0.5, high risk: > 2 ng/mL] |
0.9 |
2.5 |
3.2 |
2.9 |
1.7 |
1.2 |
2.9 |
3.3 |
4.7 |
ESR [0 to 22 mm/h in 1st h for men] |
23 |
|
|
18 |
|
|
|
|
|
Fibrinogen [200 to 400 mg/dL] |
|
128 |
119 |
132 |
178 |
186 |
218 |
208 |
213 |
Metabolic profile
|
HbA1C [%] |
7.4 |
|
|
|
|
|
|
|
|
Total cholesterol [0–200 mg/dL] |
|
198 |
|
|
|
|
|
|
|
Triglyceride [0–150 mg/dL] |
|
750 |
950 |
877 |
764 |
721 |
796 |
810 |
877 |
LDL [40–60 mg/dL] |
|
47 |
|
|
|
|
|
|
|
HDL [< 40 mg/dL] |
|
38 |
|
|
|
|
|
|
|